Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. März 2017 08:30 ET | Quelle: Evoke Pharma

Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter and Full-Year 2016 Financial Results

SOLANA BEACH, Calif., March 07, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced today...
06. März 2017 08:30 ET | Quelle: Evoke Pharma

Evoke Pharma Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares

SOLANA BEACH, Calif., March 06, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced today...
16. Februar 2017 08:45 ET | Quelle: Evoke Pharma

Evoke Pharma Announces Pricing of Public Offering of Common Stock

SOLANA BEACH, Calif., Feb. 16, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced today that...
15. Februar 2017 16:42 ET | Quelle: Evoke Pharma

Evoke Pharma Announces Proposed Public Offering of Common Stock

SOLANA BEACH, Calif., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
15. Februar 2017 08:30 ET | Quelle: Evoke Pharma

FDA Exempts Evoke from Requirement for Human Factor Validation Study

SOLANA BEACH, Calif., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, today announced that...
09. Januar 2017 08:30 ET | Quelle: Evoke Pharma

Evoke Pharma to Attend 2017 JPMorgan Healthcare Conference

SOLANA BEACH, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
04. Januar 2017 08:30 ET | Quelle: Evoke Pharma

Evoke Provides Additional Data Demonstrating Statistically Significant Benefit for Gimoti in Moderate to Severe Patients in Phase 3 Diabetic Gastroparesis Trial

SOLANA BEACH, CA, Jan. 04, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today provided...
15. Dezember 2016 16:08 ET | Quelle: Evoke Pharma

Evoke Receives Positive NDA Submission Guidance from US FDA for Gimoti

SOLANA BEACH, Calif., Dec. 15, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
09. November 2016 16:05 ET | Quelle: Evoke Pharma

Evoke Pharma Reports Third Quarter 2016 Results

SOLANA BEACH, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
01. November 2016 08:30 ET | Quelle: Evoke Pharma

Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2016 Financial Results

SOLANA BEACH, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...

Vorherige Seite

Nächste Seite